A 28-year-old woman from rural India presents with 6 months of irregular vaginal bleeding and lower abdominal pain. She reports a hydatidiform mole evacuation 4 months ago. Pelvic ultrasound shows a heterogeneous uterine mass with extensive hemorrhage and necrosis. Serum β-hCG is 850,000 mIU/mL. Histopathology reveals biphasic proliferation of pleomorphic cytotrophoblasts and multinucleated syncytiotrophoblasts with extensive hemorrhage and necrosis. The structure marked **D** in the diagram is notably absent. Which of the following best explains why the **absence of chorionic villi (D)** is the KEY HISTOLOGICAL FEATURE that distinguishes this lesion from a hydatidiform mole?

Explanation

## Why option 1 is right Choriocarcinoma is a highly malignant trophoblastic tumor composed ONLY of proliferating cytotrophoblasts and syncytiotrophoblasts with NO villous framework. This absence of chorionic villi is the KEY DISTINGUISHING HISTOLOGICAL FEATURE from hydatidiform moles (both complete and partial types), which retain abnormal but identifiable chorionic villi—hydropic and atrophic in complete moles, focal and hydropic in partial moles. The anchor fact from Robbins 10e Ch 22 and Williams Obstetrics 26e explicitly states: "ABSENCE of CHORIONIC VILLI (distinguishes from hydatidiform mole + invasive mole + normal pregnancy products)." This is the defining pathological criterion that separates choriocarcinoma from other gestational trophoblastic diseases on the GTD spectrum. ## Why each distractor is wrong - **Option 2**: While choriocarcinoma does show extensive hemorrhage and necrosis, these are secondary features (hallmark of aggressive behavior and vascular invasion). The absence of villi is NOT a consequence of hemorrhage—it is a primary histological feature reflecting the pure trophoblastic nature of the tumor. Hydatidiform moles also show hemorrhage but retain villi. - **Option 3**: Metastasis does not explain the absence of villi in the primary uterine tumor. The villi are absent at the primary site because choriocarcinoma is a non-villous trophoblastic proliferation, not because metastatic spread destroys them. - **Option 4**: This describes placental site trophoblastic tumor (PSTT), which arises from intermediate trophoblast and is a different entity in the GTD spectrum. PSTT has different histology, lower β-hCG, and is chemoresistant—distinct from choriocarcinoma. **High-Yield:** Choriocarcinoma = biphasic trophoblast (cytotrophoblast + syncytiotrophoblast) + NO villi + massive hemorrhage/necrosis + extreme β-hCG elevation + ~50% post-molar, ~25% post-term, ~25% post-miscarriage; India incidence 1:1000–1:2000 (10–40× higher than West). [cite: Robbins and Cotran Pathologic Basis of Disease, 10th ed., Ch 22; Williams Obstetrics, 26th ed.]